Treatment strategies for endometriosis
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Endometriosis is a common chronic disease that causes symptoms of pain and infertility. The pain syndrome can be quite incapacitating. The pain symptoms usually originate in the reproductive organs but can also involve the urinary or intestinal tracts if endometriosis implantation has occurred there. The presentation and physical appearance of endometriosis is extremely variable and can be characterized by a chronic intraperitoneal inflammatory process and adhesions. The only definitive diagnostic technique is laparoscopy. OBJECTIVE: To review current literature on the treatment strategies for endometriosis. METHODS: Review of Pubmed, Cochrane database and Medline for current review articles and studies regarding the current treatment strategies for endometriosis. RESULTS: Initial treatment is surgical or medical. Medical therapy is often used as a first-line therapy and can also be used in conjunction with those patients who undergo surgical therapy for pain. No medical therapy has proven effective for infertility. Medical therapy consists mostly of hormonal suppressive therapy in which the medication causes a downregulation of the hypothalamus-pituitary-ovarian pathway. Non-steroidal anti-inflammatory drugs and oral contraceptives are often used as an initial approach even without a definitive diagnosis. Progestins, such as oral norethindrone and depot medroxyprogesterone, are effective while using them but have a high recurrence rate. The norgestrol intrauterine device is also quite effective at relieving pain associated with endometriosis, especially pain arising during menses as well as from lesions in the rectovaginal tissue. Gonadotropin-releasing hormone agonists induce a pseudomenopausal state and have significant side effects, such as hot flashes and genital atrophy. 'Add-back' therapy with a progestin has been shown to relieve most of these drug related symptoms. Gonadotropin-releasing hormone agonists are also very effective at relieving symptoms of pain during treatment but are also associated with a high recurrence rate. New drug therapies that are under investigation are aromatase inhibitors and immunomodulators. Furthermore, new delivery systems are being investigated that may also improve the patient response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Revised American Society for Reproductive Medicine classification of endometriosis: 1996
American Society for Reproductive Medicine (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)81391-x · Cited by 3,018
Revised American Fertility Society Classification of Endometriosis: 1985
(1985) · Fertility and Sterility · doi:10.1016/s0015-0282(16)48430-x · Cited by 1,803
ESHRE guideline for the diagnosis and treatment of endometriosis
Kennedy, S., Bergqvist, A., Chapron, C., D’Hooghe, T., Dunselman, G., Greb, R., Hummelshoj, L., Prentice, A., & Saridogan, E. (2005) · Human Reproduction · doi:10.1093/humrep/dei135 · Cited by 1,584 · cited 2×
“In refractory disease, laparoscopic uterine nerve ablation (LUNA) and presacral neurectomy can be preformed, but neither has been clearly shown to have benefit over traditional excision [31-33] .”
BackgroundRisk of cardiovascular events and rofecoxib: cumulative meta-analysis
Jüni, P., Nartey, L., Reichenbach, S., Sterchi, R., Dieppe, P. A., & Egger, M. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17514-4 · Cited by 846
Mitwally, M. F. M., & Casper, R. F. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01705-2 · Cited by 800 · cited 1×
“Stimulating the ovary leads to an increased number of mature follicles [72] .”
BackgroundAromatase expression in endometriosis.
Noble, L. S., Simpson, E. R., Johns, A., & Bulun, S. E. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.1.8550748 · Cited by 566 · cited 1×
“Transcription of the aromatase gene is tightly controlled within endometriosis implants and can be upregulated by prostaglandin E2 [63-65] .”
BackgroundVascular endothelial growth factor (VEGF) in endometriosis
Donnez, J., Smoes, P., Gillerot, S., Casanas-Roux, F., & Nisolle, M. (1998) · Human Reproduction · doi:10.1093/humrep/13.6.1686 · Cited by 531 · cited 1×
“Vascular endothelial growth factor (VEGF) has also been identified as a possible factor that aids ectopic endometrial cells in implantation [13] .”
BackgroundSutton, C. J. G., Ewen, S. P., Whitelaw, N., & Haines, P. (1994) · Fertility and Sterility · doi:10.1016/s0015-0282(16)56990-8 · Cited by 525
Endometriosis and pelvic pain: relation to disease stage and localization
Vercellini, P., Trespidi, L., De Giorgi, O., Cortesi, I., Parazzini, F., & Crosignani, P. G. (1996) · Fertility and Sterility · doi:10.1016/s0015-0282(16)58089-3 · Cited by 457 · cited 6×
“The ASRM classification of endometriosis is performed surgically, but does not necessarily correlate with degree of pain.”
BackgroundMethodInfluentialOosterlynck, D. J., Cornillie, F. J., Waer, M., Vandeputte, M., & Koninckx, P. R. (1991) · Fertility and Sterility · doi:10.1016/s0015-0282(16)54414-8 · Cited by 441 · cited 1×
“Any decrease in these cells may lead to an increase in the number of active endometrial cells in the peritoneal cavity [14] .”
BackgroundAromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders
Mitwally, M. F. M., & Casper, R. F. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)03280-0 · Cited by 407 · cited 1×
“They are given cyclically for infertility compared with continuously if used for pain [73-76] .”
BackgroundGoswami, S. K. (2004) · Human Reproduction · doi:10.1093/humrep/deh359 · Cited by 372 · cited 1×
“They are given cyclically for infertility compared with continuously if used for pain [73-76] .”
BackgroundFisher, S. A., Reid, R. L., Van Vugt, D. A., & Casper, R. F. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)03241-7 · Cited by 347 · cited 1×
“They are given cyclically for infertility compared with continuously if used for pain [73-76] .”
BackgroundProstaglandin E2 Stimulates Aromatase Expression in Endometriosis-Derived Stromal Cells
Noble, L. S. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.2.600 · Cited by 301
Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis
Fedele, L., Bianchi, S., Zanconato, G., Portuese, A., & Raffaelli, R. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01759-3 · Cited by 290 · cited 1×
“The LNG-IUD has also been shown to decrease pain associated with rectovaginal endometriosis [46] .”
BackgroundTreatment of severe postmenopausal endometriosis with an aromatase inhibitor
Takayama, K., Zeitoun, K., Gunby, R. T., Sasano, H., Carr, B. R., & Bulun, S. E. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00022-3 · Cited by 270
Vercellini, P., Frontino, G., De Giorgi, O., Aimi, G., Zaina, B., & Crosignani, P. G. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)00608-3 · Cited by 263
Advances in the management of endometriosis: an update for clinicians
Crosignani, P., Olive, D., Bergqvist, A., & Luciano, A. (2006) · Human Reproduction Update · doi:10.1093/humupd/dmi049 · Cited by 237
Soysal, S. (2004) · Human Reproduction · doi:10.1093/humrep/deh035 · Cited by 227 · cited 1×
“One study found no change in bone density at 6 months after use of an aromatase inhibitor with an oral contraceptive in premenopausal women, and another found a decrease in bone density with the use of aromatase inhibitor with a GnRH agonist after 6 months of use in premenopausal women [71,79] .”
BackgroundLING, F. W. (1999) · Obstetrics & Gynecology · doi:10.1097/00006250-199901000-00012 · Cited by 223
Treatment of endometriosis with the antiprogesterone mifepristone (RU486)
Michael Kettel, L., Murphy, A. A., Morales, A. J., Ulmann, A., Baulieu, E. E., & Yen, S. S. C. (1996) · Fertility and Sterility · doi:10.1016/s0015-0282(16)58022-4 · Cited by 216
Zeitoun, K., Takayama, K., Michael, M. D., & Bulun, S. E. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.2.0229 · Cited by 216
Aromatase inhibitors: the next generation of therapeutics for endometriosis?
Attar, E., & Bulun, S. E. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.09.064 · Cited by 184
Schlaff, W. D., Carson, S. A., Luciano, A., Ross, D., & Bergqvist, A. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.07.1315 · Cited by 168
Evaluation of risk factors associated with endometriosis
Hemmings, R., Rivard, M., Olive, D. L., Poliquin-Fleury, J., Gagné, D., Hugo, P., & Gosselin, D. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.038 · Cited by 156
Tokushige, N., Markham, R., Russell, P., & Fraser, I. S. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.12.078 · Cited by 151 · cited 1×
“One study found that there is increased nerve fiber density and different types of nerve fibers in hysterectomy specimens from women with endometriosis when compared with those without [19] .”
BackgroundKettel, L. M., Murphy, A. A., Mortola, J. F., Liu, J. H., Ulmann, A., & Yen, S. S. C. (1991) · Fertility and Sterility · doi:10.1016/s0015-0282(16)54531-2 · Cited by 151 · cited 1×
“Matrix metalloprotease a reduction of pain, as well as decrease in visible disease at time of laparoscopy [84-87] .”
BackgroundVercellini, P., Aimi, G., Busacca, M., Apolone, G., Uglietti, A., & Crosignani, P. G. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)00613-7 · Cited by 137 · cited 1×
“In refractory disease, laparoscopic uterine nerve ablation (LUNA) and presacral neurectomy can be preformed, but neither has been clearly shown to have benefit over traditional excision [31-33] .”
BackgroundEfficacy of vaginal danazol treatment in women with recurrent deeply infiltrating endometriosis
Razzi, S., Luisi, S., Calonaci, F., Altomare, A., Bocchi, C., & Petraglia, F. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.12.077 · Cited by 100
Familial inheritance of endometriosis in a British population. A case control study
Coxhead, D., & Thomas, E. J. (1993) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443619309151773 · Cited by 97
Stegmann, B. J., Sinaii, N., Liu, S., Segars, J., Merino, M., Nieman, L. K., & Stratton, P. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.05.042 · Cited by 81 · cited 2×
“There are three main hypothesises suggested for pain, including inflammatory cells and cytokines, bleeding within the implant, and nerve irritation from implants [11,16,20,21] .”
BackgroundCobellis, L., Razzi, S., Fava, A., Severi, F. M., Igarashi, M., & Petraglia, F. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.11.058 · Cited by 71 · cited 1×
“A danazol impregnated IUD has shown to have decreased systemic effects while improving dysmenorrhea, dysparunia and pelvic pain associated with endometriosis [57] .”
BackgroundChwaliszC. Mattia-Goldberg, K., Lee, M., Elger, W., & Edmonds, A. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.07.212 · Cited by 43
Cited by
Progestagens and anti-progestagens for pain associated with endometriosis
Brown, J., Kives, S., & Akhtar, M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002122.pub2 · Cited by 250
Seracchioli, R., Mabrouk, M., Manuzzi, L., Vicenzi, C., Frasca, C., Elmakky, A., & Venturoli, S. (2009) · Human Reproduction · doi:10.1093/humrep/dep259 · Cited by 158
Seracchioli, R., Mabrouk, M., Frascà, C., Manuzzi, L., Savelli, L., & Venturoli, S. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.03.083 · Cited by 158
Continuous versus cyclic oral contraceptives for the treatment of endometriosis: a systematic review
Zorbas, K. A., Economopoulos, K. P., & Vlahos, N. F. (2015) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-015-3641-1 · Cited by 114
“Finally, oCP induce atrophy of the endometriotic tissue [26], enhance apoptosis in the ectopic endometrial tissue, and down-regulate the endometrial cell proliferation [27].”
BackgroundKulak, J., Fischer, C., Komm, B., & Taylor, H. S. (2011) · Endocrinology · doi:10.1210/en.2010-1010 · Cited by 112
Metadata
- Authors
- Rodgers, A. K., & Falcone, T.
- Venue
- Expert Opinion on Pharmacotherapy
- Publisher
- Informa Healthcare
- Published
- 2008-01-17
- Volume
- 9
- Issue
- 2
- Pages
- 243-255
- ISSN
- 1465-6566 (ISSN-L)
- 1744-7666
- OpenAlex
- W2000194898
- Cited by
- 73
- References
- 33
- FWCI
- 8.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.